144 related articles for article (PubMed ID: 31153760)
1. Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer.
Huynh-Le MP; Klapheke A; Cress R; Mell LK; Yashar CM; Einck JP; Mundt AJ; Mayadev JS
Brachytherapy; 2019; 18(5):612-619. PubMed ID: 31153760
[TBL] [Abstract][Full Text] [Related]
2. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
Bingham B; Orton A; Boothe D; Stoddard G; Huang YJ; Gaffney DK; Poppe MM
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1040-1050. PubMed ID: 28332987
[TBL] [Abstract][Full Text] [Related]
3. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
4. Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California.
Mayadev J; Klapheke A; Yashar C; Hsu IC; Kamrava M; Mundt AJ; Mell LK; Einck J; Benedict S; Valicenti R; Cress R
Gynecol Oncol; 2018 Jul; 150(1):73-78. PubMed ID: 29709291
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Body Radiation Therapy, Intensity-Modulated Radiation Therapy, and Brachytherapy Boost Modalities in Invasive Cervical Cancer: A Study of the National Cancer Data Base.
OʼDonnell B; Shiao JC; Pezzi TA; Waheed N; Sharma S; Bonnen MD; Ludwig MS
Int J Gynecol Cancer; 2018 Mar; 28(3):563-574. PubMed ID: 29324547
[TBL] [Abstract][Full Text] [Related]
6. Identifying disparities in brachytherapy delivery for locally advanced cervical cancer.
Eakin A; Wairiri L; Stadtlander W; Bruegl A; Emerson J; Williamson C; Kahn J
Brachytherapy; 2023; 22(4):461-467. PubMed ID: 37015846
[TBL] [Abstract][Full Text] [Related]
7. Trends in the utilization of brachytherapy in cervical cancer in the United States.
Han K; Milosevic M; Fyles A; Pintilie M; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):111-9. PubMed ID: 23849695
[TBL] [Abstract][Full Text] [Related]
8. Determinants of Quality Care and Mortality for Patients With Locally Advanced Cervical Cancer in Virginia.
Showalter TN; Camacho F; Cantrell LA; Anderson RT
Medicine (Baltimore); 2016 Feb; 95(8):e2913. PubMed ID: 26937934
[TBL] [Abstract][Full Text] [Related]
9. High versus low-dose rate brachytherapy for cervical cancer.
Patankar SS; Tergas AI; Deutsch I; Burke WM; Hou JY; Ananth CV; Huang Y; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2015 Mar; 136(3):534-41. PubMed ID: 25575481
[TBL] [Abstract][Full Text] [Related]
10. Survival Benefit of Adjuvant Brachytherapy After Hysterectomy With Positive Surgical Margins in Cervical Cancer.
Li R; Shinde A; Chen YJ; Amini A; Lee S; Dellinger T; Han E; Wakabayashi M; Nelson R; Beriwal S; Glaser S
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):373-382. PubMed ID: 29890264
[TBL] [Abstract][Full Text] [Related]
11. The effect of marriage on stage at diagnosis and survival in women with cervical cancer.
El Ibrahimi S; Pinheiro PS
Psychooncology; 2017 May; 26(5):704-710. PubMed ID: 26810012
[TBL] [Abstract][Full Text] [Related]
12. Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States: A Surveillance, Epidemiology, and End-Results Study.
Han K; Colson-Fearon D; Liu ZA; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):143-153. PubMed ID: 37951548
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.
Nugent EK; Case AS; Hoff JT; Zighelboim I; DeWitt LL; Trinkhaus K; Mutch DG; Thaker PH; Massad LS; Rader JS
Gynecol Oncol; 2010 Mar; 116(3):438-41. PubMed ID: 19896180
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
Ito K; Shimizuguchi T; Karasawa K
Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
[TBL] [Abstract][Full Text] [Related]
15. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
16. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
Petereit DG; Sarkaria JN; Potter DM; Schink JC
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
[TBL] [Abstract][Full Text] [Related]
17. Brachytherapy Boost Utilization and Survival in Unfavorable-risk Prostate Cancer.
Johnson SB; Lester-Coll NH; Kelly JR; Kann BH; Yu JB; Nath SK
Eur Urol; 2017 Nov; 72(5):738-744. PubMed ID: 28688613
[TBL] [Abstract][Full Text] [Related]
18. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.
Gill BS; Lin JF; Krivak TC; Sukumvanich P; Laskey RA; Ross MS; Lesnock JL; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1083-90. PubMed ID: 25216857
[TBL] [Abstract][Full Text] [Related]
19. Multiplicative disadvantage of being an unmarried and inadequately insured woman living in poverty with colon cancer: historical cohort exploration in California.
Levitz NR; Haji-Jama S; Munro T; Gorey KM; Luginaah IN; Bartfay E; Zou G; Wright FC; Kanjeekal SM; Hamm C; Balagurusamy MK; Holowaty EJ
BMC Womens Health; 2015; 15():8. PubMed ID: 25783640
[TBL] [Abstract][Full Text] [Related]
20. The influence of marital status on the stage at diagnosis, treatment, and survival of adult patients with gastric cancer: a population-based study.
Zhang J; Gan L; Wu Z; Yan S; Liu X; Guo W
Oncotarget; 2017 Apr; 8(14):22385-22405. PubMed ID: 26894860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
